Carregant...
Selective Targeting of TNF Receptors as a Novel Therapeutic Approach
Tumor necrosis factor (TNF) is a central regulator of immunity. Due to its dominant pro-inflammatory effects, drugs that neutralize TNF were developed and are clinically used to treat inflammatory and autoimmune diseases, such as rheumatoid arthritis, inflammatory bowel disease and psoriasis. Howeve...
Guardat en:
| Publicat a: | Front Cell Dev Biol |
|---|---|
| Autors principals: | , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Frontiers Media S.A.
2020
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7264106/ https://ncbi.nlm.nih.gov/pubmed/32528961 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fcell.2020.00401 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|